Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. [electronic resource]
Producer: 19890913Description: 1524-9 p. digitalISSN:- 0022-1767
- Animals
- Bone Marrow -- immunology
- Bone Marrow Transplantation
- Clone Cells -- immunology
- Cytotoxicity, Immunologic
- Female
- Graft Rejection
- Graft Survival
- Graft vs Host Disease -- prevention & control
- Immunity, Innate -- radiation effects
- Immunization, Passive
- Interleukin-1 -- pharmacology
- Isoantigens -- genetics
- Killer Cells, Natural -- classification
- Lymphocyte Activation -- radiation effects
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C3H
- Mice, Inbred C57BL
- Phenotype
- Radiation Chimera
- Recombinant Proteins -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.